Millennium Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,579
Closed -$1.62M 6165
2025
Q4
$1.46M Buy
10,579
+607
+6% +$79.5K ﹤0.01% 4207
2025
Q3
$1.28M Sell
9,972
-830,799
-99% -$101M ﹤0.01% 4422
2025
Q2
$102M Buy
840,771
+417,088
+98% +$47M 0.05% 383
2025
Q1
$47.2M Buy
423,683
+137,096
+48% +$14.6M 0.03% 809
2024
Q4
$27.9M Buy
286,587
+246,394
+613% +$26.3M 0.01% 1243
2024
Q3
$4.62M Buy
40,193
+31,330
+353% +$3.55M ﹤0.01% 2908
2024
Q2
$944K Sell
8,863
-262,380
-97% -$26.3M ﹤0.01% 4146
2024
Q1
$26.2M Sell
271,243
-127,057
-32% -$13M 0.01% 1315
2023
Q4
$40.2M Buy
398,300
+362,552
+1,014% +$35M 0.02% 955
2023
Q3
$3.64M Sell
35,748
-23,406
-40% -$2.38M ﹤0.01% 3014
2023
Q2
$5.97M Sell
59,154
-888,068
-94% -$88.8M ﹤0.01% 2504
2023
Q1
$87.1M Buy
947,222
+934,095
+7,116% +$81.6M 0.05% 394
2022
Q4
$1.19M Sell
13,127
-18,939
-59% -$1.6M ﹤0.01% 3993
2022
Q3
$2.44M Buy
32,066
+26,412
+467% +$2.19M ﹤0.01% 3565
2022
Q2
$478K Sell
5,654
-308,670
-98% -$27.1M ﹤0.01% 4988
2022
Q1
$27.6M Sell
314,324
-528,345
-63% -$45.7M 0.01% 1083
2021
Q4
$73.7M Buy
842,669
+56,802
+7% +$4.72M 0.04% 506
2021
Q3
$64.3M Buy
785,867
+667,519
+564% +$60.1M 0.04% 512
2021
Q2
$10.8M Buy
118,348
+63,675
+116% +$5.67M 0.01% 1809
2021
Q1
$4.67M Buy
54,673
+24,114
+79% +$2.16M ﹤0.01% 2642
2020
Q4
$2.89M Sell
30,559
-107,089
-78% -$9.36M ﹤0.01% 2931
2020
Q3
$12K Sell
137,648
-730,454
-84% -$63.3M 0.01% 1117
2020
Q2
$75.8M Buy
868,102
+127,132
+17% +$11M 0.1% 163
2020
Q1
$61.1M Buy
+740,970
New +$66.1M 0.14% 129
2019
Q3
Sell
-352,466
Closed -$32.2M 4442
2019
Q2
$32.2M Sell
352,466
-773,026
-69% -$65.4M 0.05% 533
2019
Q1
$97M Buy
1,125,492
+510,237
+83% +$41M 0.15% 152
2018
Q4
$47.3M Sell
615,255
-941,759
-60% -$73.3M 0.07% 362
2018
Q3
$120M Buy
1,557,014
+564,641
+57% +$41.7M 0.15% 144
2018
Q2
$67.2M Sell
992,373
-108,463
-10% -$7.48M 0.09% 286
2018
Q1
$79.8M Buy
1,100,836
+540,968
+97% +$41.2M 0.11% 251
2017
Q4
$42.1M Sell
559,868
-370,357
-40% -$27.9M 0.06% 490
2017
Q3
$71.6M Buy
930,225
+840,246
+934% +$63.5M 0.11% 226
2017
Q2
$6.73M Sell
89,979
-1,445,258
-94% -$102M 0.01% 1303
2017
Q1
$102M Buy
+1,535,237
New +$102M 0.19% 119
2016
Q4
Sell
-319,309
Closed -$22.6M 3601
2016
Q3
$22.6M Buy
319,309
+295,283
+1,229% +$21.5M 0.04% 529
2016
Q2
$1.78M Buy
+24,026
New +$1.66M ﹤0.01% 1843
2016
Q1
Sell
-221,219
Closed -$17.1M 3542
2015
Q4
$17.1M Buy
221,219
+73,365
+50% +$5.83M 0.04% 639
2015
Q3
$12.2M Sell
147,854
-156,602
-51% -$13.9M 0.02% 823
2015
Q2
$26.8M Buy
304,456
+91,858
+43% +$8.43M 0.05% 488
2015
Q1
$18.8M Sell
212,598
-188,635
-47% -$16.7M 0.04% 694
2014
Q4
$33.3M Sell
401,233
-9,850
-2% -$816K 0.07% 372
2014
Q3
$34.7M Buy
411,083
+348,050
+552% +$28.2M 0.09% 263
2014
Q2
$5.11M Buy
+63,033
New +$4.96M 0.01% 1205
2014
Q1
Sell
-40,012
Closed -$2.88M 3763
2013
Q4
$2.88M Buy
+40,012
New +$2.78M 0.01% 1556
2013
Q3
Sell
-5,028
Closed -$319K 3495
2013
Q2
$319K Buy
+5,028
New +$327K ﹤0.01% 2556

Other funds holding NVS

Millennium Management's NVS Position: Q1 2026 in Review

Millennium Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 10,579 shares — an estimated $1.62M sold.

Millennium Management first reported a position in NVS in Q2 2013 and held it in 45 quarters. The position peaked at $120M in Q3 2018. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Millennium Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 10,579 Novartis shares in Q1 2026, an estimated $1.62M.
  • Millennium Management first reported a position in Novartis in Q2 2013 and held it in 45 quarters.
  • Millennium Management's Novartis position peaked at $120M in Q3 2018.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.